Literature DB >> 11048800

Gastric cardia intestinal metaplasia: biopsy follow-up of 85 patients.

N S Goldstein1.   

Abstract

BACKGROUND: Gastric cardia intestinal metaplasia (CIM), denoted by goblet cells is common. The frequency of persistent CIM is unknown.
METHODS: 85 patients with CIM and follow-up endoscopies were prospectively identified during the time period of 10/6/94-12/21/97. The presence of goblet cells was the defining feature of CIM, other metaplastic cell types were not evaluated. AU 85 patients initially had biopsies that straddled the squamocolumnar junction (SCJ) showed CIM, an otherwise normal proximal stomach, lower esophagus, and squamocolumnar junction. The SCJ lay within the 2 cm of mucosa immediately proximal to the uppermost gastric fold and overlaid the junction of the tubular esophagus and the saccular dilatation of the stomach in all patients. The patients underwent endoscopy for many reasons. They were randomly identified based on the absence of a hiatal hernia and the presence of CIM.
RESULTS: Ten of the 85 patients had CIM on repeat biopsy. Among patients with no CIM in the first repeat endoscopy, the degree of cardia inflammation decreased between the initial and first repeat endoscopy, whereas there was no change in the amount of inflammation among patients who had CIM in the first repeat endoscopy. The changes in mean inflammation score was significantly different between the two groups (P = .024). Twenty-two patients underwent a second repeat endoscopy and five had a third repeat endoscopy. Including all follow-up biopsies, six of the 85 patients (7%) had CIM. Four patients who did not have CIM on initial repeat endoscopy had CIM on their second repeat endoscopy, probably reflecting sampling issues. None of the biopsies had dysplasia.
CONCLUSIONS: Cardia inflammation is a stimulus for cardia intestinal metaplasia, and a reduction in inflammation may allow the metaplastic mucosa to revert to normal.

Entities:  

Mesh:

Year:  2000        PMID: 11048800     DOI: 10.1038/modpathol.3880198

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  10 in total

Review 1.  Report of an Amsterdam working group on Barrett esophagus.

Authors:  G J A Offerhaus; P Correa; S van Eeden; K Geboes; P Drillenburg; M Vieth; M L van Velthuysen; H Watanabe; P Sipponen; F J W ten Kate; F T Bosman; A Bosma; A Ristimaki; H van Dekken; R Riddell; G N J Tytgat
Journal:  Virchows Arch       Date:  2003-09-27       Impact factor: 4.064

Review 2.  Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists.

Authors:  Bita V Naini; Rhonda F Souza; Robert D Odze
Journal:  Am J Surg Pathol       Date:  2016-05       Impact factor: 6.394

Review 3.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 4.  Barrett esophagus: histology and pathology for the clinician.

Authors:  Robert D Odze
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-07-07       Impact factor: 46.802

5.  Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology.

Authors:  A Couvelard; J M Cauvin; D Goldfain; A Rotenberg; M Robaszkiewicz; J F Fléjou
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

6.  The Prognostic Impact of Extent of Vascular Invasion in Follicular Thyroid Carcinoma.

Authors:  David Leong; Anthony J Gill; John Turchini; Michael Waller; Roderick Clifton-Bligh; Anthony Glover; Mark Sywak; Stan Sidhu
Journal:  World J Surg       Date:  2022-08-28       Impact factor: 3.282

7.  The columnar-lined mucosa at the gastroesophageal junction in non-human primates.

Authors:  Carlos A Rubio; Edward J Dick; Natalia E Schlabritz-Loutsevitch; Abiel Orrego; Gene B Hubbard
Journal:  Int J Clin Exp Pathol       Date:  2008-01-20

8.  The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?

Authors:  A Meining; R Ott; I Becker; S Hahn; J Mühlen; M Werner; H Höfler; M Classen; W Heldwein; T Rösch
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 9.  Histology of Barrett's Metaplasia: Do Goblet Cells Matter?

Authors:  Robert Odze
Journal:  Dig Dis Sci       Date:  2018-08       Impact factor: 3.199

10.  The utility of a methylation panel in the assessment of clinical response to radiofrequency ablation for Barrett's esophagus.

Authors:  Wladyslaw Januszewicz; Vinod V Subhash; William Waldock; Daniel I Fernando; Giorgio Bartalucci; Hamza Chettouh; Ahmad Miremadi; Maria O'Donovan; Rebecca C Fitzgerald; Massimiliano di Pietro
Journal:  EBioMedicine       Date:  2020-07-22       Impact factor: 8.143

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.